BGM Group Ltd. Class A Ordinary Shares (BGM)

• Market cap: $894M
• 1 day: -6.22%
• 5 days: -12.38%
• 1 month: 8.88%
• 3 months: 31.43%
• 6 months: 48.87%
• Year to date: 2.91%
• 1 year: 235.77%
• 5 years: -81.60%
• 10 years: -81.60%

About: BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Employees: 323

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.01% more ownership

Funds ownership: 0% [Q2] → 0.01% (+0.01%) [Q3]

0% more funds holding

Funds holding: 2 [Q2] → 2 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

82% less capital invested

Capital invested by funds: $20.1K [Q2] → $3.59K (-$16.5K) [Q3]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1